CereVasc
Pre-clinicalThe CereVasc eShunt® device is intended to improve patient outcomes and redefine the treatment of communicating hydrocephalus
Founded
2015
Focus
NeuroscienceMedical Devices
About
The CereVasc eShunt® device is intended to improve patient outcomes and redefine the treatment of communicating hydrocephalus
Funding History
2Total raised: $40M
Series B$25MPerceptive AdvisorsMar 15, 2022
Series A$15MPerceptive AdvisorsSep 15, 2020
Company Info
TypePrivate
Founded2015
LocationBurlington, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile